SODIUM FLUORIDE F-18 200 mCi in 1 mL INTRAVENOUS INJECTION, SOLUTION

Known as: SODIUM FLUORIDE F-18 200 mCi in 1 mL INTRAVENOUS INJECTION, SODIUM FLUORIDE F-18 200 mCi in 1 mL INTRAVENOUS INJECTION [Sodium Fluoride F 18], SODIUM FLUORIDE F-18 200 mCi in 1 mL INTRAVENOUS INJECTION, SOLUTION [Sodium Fluoride F 18] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
0119932018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
We explored the presence of both reserve and resilience in late-converter mild cognitive impairment due to Alzheimer’s disease… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2015
2015
Alzheimer's disease (AD) is the most common form of dementia, with no disease-modifying treatment yet available. Early detection… (More)
  • figure 1
  • figure 2
  • figure 4
  • table 3
  • figure 5
Is this relevant?
2013
2013
Deficient N-methyl-D-aspartate (NMDA) receptor transmission is thought to underlie schizophrenia. An approach for normalizing… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2011
2011
BACKGROUND/AIMS To study how vascular disease and Alzheimer-typical biomarkers relate to cognitive performance in mild cognitive… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2009
2009
AIM To evaluate the frequency of mild cognitive impairment (MCI) subtypes and their neuropsychological characteristics in our… (More)
Is this relevant?
Review
2002
Review
2002
The diagnosis of Mild Cognitive Impairment (MCI) as defined by Petersen et al. (1997), is based uniquely on clinical observations… (More)
Is this relevant?
1993
1993
 
Is this relevant?